Loading…
Cartesian Growth Corporation III is projected to rise to $16.33 by 2027, a +37% move from its current price of $11.90. CGCT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $11.69 | $11.91 | $12.13 | +0.05% |
| Jul 14 | $11.61 | $11.91 | $12.23 | +0.10% |
| Jul 15 | $11.54 | $11.92 | $12.30 | +0.15% |
| Jul 16 | $11.49 | $11.92 | $12.37 | +0.20% |
| Jul 17 | $11.45 | $11.93 | $12.43 | +0.25% |
| Jul 18 | $11.41 | $11.94 | $12.49 | +0.30% |
| Jul 19 | $11.37 | $11.94 | $12.54 | +0.35% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $11.37 | $11.94 | $12.54 | +0.35% |
| Week 2 | $11.18 | $11.98 | $12.84 | +0.70% |
| Week 3 | $11.05 | $12.02 | $13.08 | +1.05% |
| Week 4 | $10.95 | $12.07 | $13.30 | +1.40% |
| Week 5 | $10.86 | $12.11 | $13.50 | +1.76% |
| Week 6 | $10.78 | $12.15 | $13.69 | +2.11% |
| Week 7 | $10.72 | $12.19 | $13.87 | +2.47% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cartesian Growth Corporation III is a special purpose acquisition company (SPAC) that focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It was incorporated in 2024 and is based in New York, New York. On June 5, 2026, Cartesian Growth Corporation III was acquired by Factorial Inc.
in a reverse merger transaction. The company does not have significant operations beyond pursuing a business combination strategy.
CGCT trades under the symbol CGCT. The entity’s structure and focus align with the SPAC model, concentrating on pursuing a strategic transaction rather than operating ongoing businesses at this time.
These details establish CGCT as a merger-focused vehicle with a defined corporate domicile and a recent corporate action that completed a reverse merger, shaping its current market positioning and price trajectory.
CGCT is currently priced at $11.90 and has a market capitalization of $492.66M, ranking 2914 by size. The stock sits at a level that, in the near term, reflects a neutral position with room for both upside and downside according to the forecast.
The year-by-year outlook shows a gradual upshift from 2026 onward, with the 2026 average price at $11.90, implying little immediate change from today on average. From 2027 onward, the model projects stronger gains: 2027 avg $16.33; 2028 avg $19.31; 2029 avg $20.39; 2030 avg $23.02, with progressively higher targets through 2050 (2031 avg $23.80; 2032 avg $24.45; 2033 avg $30.03; 2034 avg $34.33; 2035 avg $37.21; 2040 avg $50.56; 2050 avg $106.90).
The forecast includes clear upside potential alongside substantial variability, with max values climbing to as high as $192.40 in 2050 and a long-run bullish sentiment across the horizon.
A major floor 31.5% below — a decisive break under it would weaken the trend.
The nearest floor, 17.1% below — buyers have tended to step in here.
The nearest ceiling, 13.4% above — a clean break opens room to run.
A major ceiling 29.7% above — clearing it would confirm fresh momentum.
Key CGCT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CGCT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $12.38 | Sell | $12.19 | Sell |
| MA 10 | $12.00 | Sell | $11.95 | Sell |
| MA 20 | $11.19 | Buy | $11.48 | Buy |
| MA 50 | $10.66 | Buy | $10.90 | Buy |
| MA 100 | $10.47 | Buy | $10.60 | Buy |
| MA 200 | $10.29 | Buy | $10.39 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.28 | Neutral |
| Stoch RSI (14) | 60.59 | Neutral |
| CCI (20) | 56.63 | Neutral |
| Williams %R (14) | -40.66 | Info |
| MACD (12,26,9) | 0.12 | Buy |
| ROC (12) | 15.36 | Buy |
| Bollinger %B (20,2) | 0.69 | Neutral |
| Stochastic %K (14) | 59.34 | Neutral |
| TRIX (15) | 0.57 | Buy |
| Awesome (5,34) | 1.54 | Buy |
| Ultimate (7,14,28) | 59.74 | Neutral |
| Momentum (10) | 1.64 | Buy |
| Aroon Osc (25) | 12.00 | Buy |
| Hull MA (9) | 12.24 | Sell |
| ADX (14) | 32.29 | Buy |
| ATR (14) | 0.31 | Info |
The near-term picture is bullish sentiment, supported by a current RSI of 60. The stock trades above both the 50-day and 200-day simple moving averages, with SMA50 at $10.66 and SMA200 at $10.29.
Near-term support is identified at $9.86, with resistance at $13.50. The 30-day trading range spans from $10.54 to $13.44, indicating a solid zone for price action in the coming weeks. Annualized volatility stands at 40%, underscoring notable price fluctuations around the current level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $9.86 | $11.90 | $16.46 | 0% | Neutral | |
| $13.07 | $16.33 | $21.56 | +37% | Bullish | |
| $15.06 | $19.31 | $26.37 | +62% | Bullish | |
| $15.58 | $20.39 | $28.61 | +71% | Bullish | |
| $17.26 | $23.02 | $33.03 | +93% | Bullish | |
| $17.54 | $23.80 | $34.84 | +100% | Bullish | |
| $17.74 | $24.45 | $36.44 | +106% | Bullish | |
| $21.47 | $30.03 | $45.48 | +152% | Bullish | |
| $24.20 | $34.33 | $52.77 | +188% | Bullish | |
| $25.88 | $37.21 | $58.00 | +213% | Bullish | |
| $33.09 | $50.56 | $83.54 | +325% | Bullish | |
| $63.08 | $106.90 | $192.40 | +798% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $10.39 | $12.21 | $14.69 | +2.57% |
| August 2026 | $10.25 | $12.13 | $14.76 | -0.66% |
| September 2026 | $10.46 | $12.45 | $15.29 | +2.69% |
| October 2026 | $10.89 | $13.03 | $16.13 | +4.65% |
| November 2026 | $10.93 | $13.13 | $16.37 | +0.78% |
| December 2026 | $10.88 | $13.13 | $16.46 | -0.05% |
Click any year to see its month-by-month CGCT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CGCT is projected to trade between $9.86 and $16.46, averaging $11.90 — a potential gain of 0% from today's $11.90. Price action looks broadly range-bound.
Cartesian Growth Corporation III's 2027 outlook centres on $16.33, within a $13.07 to $21.56 range. That is up +37% on the projected 2026 average. That marks a +37% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, CGCT could reach as high as $26.37, with a base case around $19.31 and support toward $15.06 — roughly +62% from $11.90. Momentum favours further upside here.
Expect CGCT to range from $15.58 to $28.61 through 2029. The $20.39 average target implies a +71% move from current prices. That is up +6% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The CGCT price prediction for 2030 points to an average of $23.02 (low $17.26, high $33.03) — a potential gain of +93% on today's $11.90. Momentum favours further upside here.
In 2031, CGCT is projected to trade between $17.54 and $34.84, averaging $23.80 — a potential gain of +100% from today's $11.90. That is up +3% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Cartesian Growth Corporation III's 2032 outlook centres on $24.45, within a $17.74 to $36.44 range. That is up +3% on the projected 2031 average. That marks a +106% change versus current levels. Momentum favours further upside here.
By 2033, CGCT could reach as high as $45.48, with a base case around $30.03 and support toward $21.47 — roughly +152% from $11.90. Buyers look set to stay in control over this stretch.
Expect CGCT to range from $24.20 to $52.77 through 2034. The $34.33 average target implies a +188% move from current prices. That is up +14% on the projected 2033 average. Momentum favours further upside here.
The CGCT price prediction for 2035 points to an average of $37.21 (low $25.88, high $58.00) — a potential gain of +213% on today's $11.90. Buyers look set to stay in control over this stretch.
In 2040, CGCT is projected to trade between $33.09 and $83.54, averaging $50.56 — a potential gain of +325% from today's $11.90. That is up +36% on the projected 2035 average. Momentum favours further upside here.
Cartesian Growth Corporation III's 2050 outlook centres on $106.90, within a $63.08 to $192.40 range. That is up +111% on the projected 2040 average. That marks a +798% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in CGCT today (≈ 84.033613 CGCT) could be worth
$8,983.12
+$7,983.12 (+798%) by 2050 · US Dollar
Based on the average projected CGCT price of $106.9 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CGCTwould be worth at today's price.
$1,000 invested in CGCT on Jun 24, 2025 (≈ 99.900098 CGCT) would be worth
$1,188.81
+$188.81 (+18.9%) today · 1.19× · US Dollar
Based on a CGCT entry price of $10.01 vs. today's $11.9.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $12.53 | $949.72 | -5.0% |
| 1 month ago | $10.41 | $1,143.13 | +14.3% |
| 3 months ago | $10.27 | $1,158.71 | +15.9% |
| 6 months ago | $10.12 | $1,175.89 | +17.6% |
| All time ago | $10.01 | $1,188.81 | +18.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CGCT forecast.
Our base-case forecast reaches $24.00 around 2032.
Implied market cap at $24.00: $662.4M
The multi-year forecast shows a clear upward trajectory across the horizon. By 2027 the average forecast price is $16.33 with an ROI of 37.3%, and the outlook strengthens further in later years with 2028 avg $19.31 (ROI 62.3%), 2029 avg $20.39 (ROI 71.4%), and 2030 avg $23.02 (ROI 93.4%).
The growth continues toward 2040, where the average forecast is $50.56 (ROI 324.8%), and by 2050 the average forecast reaches $106.90 with an extraordinary ROI of 798.3%. Overall sentiment remains bullish across the longer horizon, though these figures are estimates and not guarantees. Higher max values illustrate substantial upside potential as conditions evolve, while the forecast acknowledges inherent uncertainty.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $23.02 with a min of $17.26 and a max of $33.03. The implied ROI is 93.4% and the sentiment is bullish.
Forecasts indicate a bullish trend after 2026, with the 2027 average at $16.33 (ROI 37.3%), 2028 at $19.31 (ROI 62.3%), and 2030 at $23.02 (ROI 93.4%). These are estimates, not guarantees, and investment risk varies with market conditions.
Yes. The 2040 forecast shows an average price of $50.56 with a min of $33.09 and a max of $83.54, and a forecasted ROI of 324.8%, suggesting a substantial potential move toward that level.
For 2026, the min price is $9.86, the average is $11.90, and the max is $16.46, with an ROI of 0% and neutral sentiment. The 30-day range is $10.54–$13.44.
Current price is $11.90. By 2050, the average forecast price is $106.90 with a max of $192.40 and a min of $63.08, representing an ROI of 798.3% and bullish sentiment.
Cartesian Growth Corporation III Community Discussion
0Share your Cartesian Growth Corporation III price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.